Atypical protein kinase C phosphorylates IKKalphabeta in transformed non-malignant and malignant prostate cell survival.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cancer Letters

• Publication date

  2008-11-08

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.canlet.2008.05.023PMID 18571841
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein kinase Cδ signaling downstream of the EGF receptor mediates migration and invasiveness of prostate cancer cells

  2006cited by this paper
• Requirement of androgen-dependent activation of protein kinase Czeta for androgen-dependent cell proliferation in LNCaP Cells and its roles in transition to androgen-independent cells.

  2006cited by this paper
• Protein kinase Cdelta signaling downstream of the EGF receptor mediates migration and invasiveness of prostate cancer cells.

  2006cited by this paper
• Protein kinase C-{alpha} mediates epidermal growth factor receptor transactivation in human prostate cancer cells.

  2005cited by this paper
• Protein kinase C-α mediates epidermal growth factor receptor transactivation in human prostate cancer cells

  2005cited by this paper
• Cyclin-dependent kinase activating kinase/Cdk7 co-localizes with PKC-iota in human glioma cells.

  2005cited by this paper
• Molecular mechanisms of protein kinase C-induced apoptosis in prostate cancer cells.

  2005cited by this paper
• Protein kinase Cgamma regulates myosin IIB phosphorylation, cellular localization, and filament assembly.

  2005cited by this paper
• TNF-alpha-mediated apoptosis in normal human prostate epithelial cells and tumor cell lines.

  2004cited by this paper
• Protein kinase C‐α in prostate cancer

  2004cited by this paper
• Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression.

  2004cited by this paper
• Integrin signaling links protein kinase Cɛ to the protein kinase B/Akt survival pathway in recurrent prostate cancer cells

  2004cited by this paper
• Nuclear Factor-κB Is Constitutively Activated in Prostate Cancer In vitro and Is Overexpressed in Prostatic Intraepithelial Neoplasia and Adenocarcinoma of the Prostate

  2004cited by this paper
• Inhibitory effect of epidermal growth factor on resveratrol-induced apoptosis in prostate cancer cells is mediated by protein kinase C-alpha.

  2004cited by this paper
• IκB kinases: key regulators of the NF-κB pathway

  2004cited by this paper
• Molecular determinants of resistance to antiandrogen therapy

  2004cited by this paper
• TNF-α-mediated apoptosis in normal human prostate epithelial cells and tumor cell lines

  2004cited by this paper
• Protein kinase C-alpha in prostate cancer.

  2004cited by this paper
• IkappaB kinases: key regulators of the NF-kappaB pathway.

  2004cited by this paper
• Protein kinase C μ is down-regulated in androgen-independent prostate cancer

  2003cited by this paper
• Protein kinase C mu is down-regulated in androgen-independent prostate cancer.

  2003cited by this paper
• Metallothionein 2A interacts with the kinase domain of PKCmu in prostate cancer.

  2003cited by this paper
• Antisense oligonucleotides in the treatment of non-small-cell lung cancer.

  2003cited by this paper
• Adenovirus-mediated inhibition of NF-kappaB confers chemo-sensitization and apoptosis in prostate cancer cells.

  2003cited by this paper
• Human glioma PKC‐ι and PKC‐βII phosphorylate cyclin‐dependent kinase activating kinase during the cell cycle

  2002cited by this paper
• Diacylglycerol (DAG)-lactones, a New Class of Protein Kinase C (PKC) Agonists, Induce Apoptosis in LNCaP Prostate Cancer Cells by Selective Activation of PKCα*

  2002cited by this paper
• The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells.

  2002cited by this paper
• Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells.

  2002cited by this paper
• Mechanisms of constitutive NF‐κB activation in human prostate cancer cells

  2002cited by this paper
• Human glioma PKC-iota and PKC-betaII phosphorylate cyclin-dependent kinase activating kinase during the cell cycle.

  2002cited by this paper
• Ultrastructural changes in the corpus allatum after azadirachtin and 20-hydroxyecdysone treatment in adult females of Labidura riparia (Dermaptera).

  2002cited by this paper
• Her-2/neu oncogene amplification in clinically localised prostate cancer.

  2002cited by this paper
• The development of androgen-independent prostate cancer

  2001cited by this paper
• Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53.

  2001cited by this paper
• Targeted Disruption of the ζPKC Gene Results in the Impairment of the NF-κB Pathway

  2001cited by this paper
• Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer

  2001cited by this paper
• NF-κB Activation Mediates Doxorubicin-induced Cell Death in N-type Neuroblastoma Cells*

  2001cited by this paper
• NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells.

  2001cited by this paper
• Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.

  2001cited by this paper
• NF-κB/RelA transactivation is required for atypical protein kinase Cι-mediated cell survival

  2001cited by this paper
• Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway.

  2001cited by this paper
• NF-kappaB/RelA transactivation is required for atypical protein kinase C iota-mediated cell survival.

  2001cited by this paper
• Involvement of protein kinase C delta (PKCdelta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCdelta.

  2000cited by this paper
• Superoxide-induced Stimulation of Protein Kinase C via Thiol Modification and Modulation of Zinc Content*

  2000cited by this paper
• Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen.

  1999cited by this paper
• Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer.

  1999cited by this paper
• Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation.

  1999cited by this paper
• Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model.

  1999cited by this paper
• Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis.

  1999cited by this paper
• The interaction of p62 with RIP links the atypical PKCs to NF‐κB activation

  1999cited by this paper
• Constitutive activation of IκB kinase α and NF-κB in prostate cancer cells is inhibited by ibuprofen

  1999cited by this paper
• Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation

  1999cited by this paper
• IEX-1L, an Apoptosis Inhibitor Involved in NF-κB-Mediated Cell Survival

  1998cited by this paper
• Death receptors: signaling and modulation.

  1998cited by this paper
• IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival.

  1998cited by this paper
• NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation.

  1998cited by this paper
• NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176

  1998cited by this paper
• MEKK1 activates both IkappaB kinase alpha and IkappaB kinase beta.

  1998cited by this paper
• Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18.

  1997cited by this paper
• Transforming Growth Factor-b 1 Inhibits Membrane Association of Protein Kinase C a in a Human Prostate Cancer

  1997cited by this paper
• Atypical Protein Kinase C ι Protects Human Leukemia Cells against Drug-induced Apoptosis*

  1997influential reference
• Transforming growth factor-beta1 inhibits membrane association of protein kinase C alpha in a human prostate cancer cell line, PC3.

  1997cited by this paper
• A biochemist's view of long-term potentiation.

  1996cited by this paper
• Persistent membrane translocation of protein kinase C alpha during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells.

  1996cited by this paper
• Different mechanisms control signal‐induced degradation and basal turnover of the NF‐kappaB inhibitor IkappaB alpha in vivo.

  1996influential reference
• NF-kappa B: ten years after.

  1996cited by this paper
• TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex.

  1996cited by this paper
• NF-κB: Ten Years After

  1996cited by this paper
• Downregulation of protein kinase C suppresses induction of apoptosis in human prostatic carcinoma cells.

  1996cited by this paper
• Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation

  1995cited by this paper
• Phorbol ester treatment of U937 cells with altered protein kinase C content and distribution induces cell death rather than differentiation.

  1995cited by this paper
• Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer.

  1995cited by this paper
• Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters.

  1994cited by this paper
• Overexpression of protein kinase C-zeta stimulates leukemic cell differentiation.

  1994cited by this paper
• Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.

  1992cited by this paper
• Growth kinetics of microscopic hepatocellular neoplasms in carcinogen-resistant and carcinogen-responsive strains of mice.

  1992cited by this paper
• Studies and perspectives of protein kinase C.

  1986cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate.

  1941cited by this paper

• PKC in cancer: A dual role in cancer promotion and suppression

  2025cites this paper
• Protein Kinase C at the Crossroad of Mutations, Cancer, Targeted Therapy and Immune Response

  2023cites this paper
• 14-3-3 and Smad2/3 are crucial mediators of atypical-PKCs: Implications for neuroblastoma progression

  2023cites this paper
• Atypical PKCs activate Vimentin to facilitate prostate cancer cell motility and invasion

  2021cites this paper
• IKKβ Kinase Promotes Stemness, Migration, and Invasion in KRAS-Driven Lung Adenocarcinoma Cells

  2020cites this paper
• Clinical significance of atypical protein kinase C (PKCι and PKCζ) and its relationship with yes-associated protein in lung adenocarcinoma

  2019cites this paper
• Role of Oncogenic Protein Kinase C-iota in Melanoma Progression; A Study Based on Atypical Protein Kinase-C Inhibitors

  2019influential citation
• The Dual Roles of the Atypical Protein Kinase Cs in Cancer.

  2019cites this paper
• Atypical Protein Kinase Cs in Melanoma Progression

  2019cites this paper
• Oncogenic PKC-ι activates Vimentin during epithelial-mesenchymal transition in melanoma; a study based on PKC-ι and PKC-ζ specific inhibitors

  2018cites this paper
• Inflammation and NF-κB Signaling in Prostate Cancer: Mechanisms and Clinical Implications

  2018cites this paper
• Inhibition of atypical protein kinase C-ι effectively reduces the malignancy of prostate cancer cells by downregulating the NF-κB signaling cascade

  2018cites this paper
• FOXO1 regulates oncogenic PKC-ι expression in melanoma inversely to c-Jun in an autocrine manner via IL-17E and ICAM-1 activation

  2018cites this paper
• Identification of novel cancer fusion genes using chromosome breakpoint screening.

  2017cites this paper
• Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis

  2017cites this paper
• Lineage Specification from Prostate Progenitor Cells Requires Gata3-Dependent Mitotic Spindle Orientation

  2017cites this paper
• Molecular Control of Atypical Protein Kinase C: Tipping the Balance between Self-Renewal and Differentiation.

  2016cites this paper
• Atypical Protein Kinase C Zeta: Potential Player in Cell Survival and Cell Migration of Ovarian Cancer

  2015cites this paper
• Loss of the Polarity Protein PAR3 Activates STAT3 Signaling via an Atypical Protein Kinase C (aPKC)/NF-κB/Interleukin-6 (IL-6) Axis in Mouse Mammary Cells*

  2015influential citation
• Spatial Regulation of the Polarity Protein aPKC During Asymmetric Cell Division of Drosophila Neuroblasts

  2015cites this paper
• Atypical protein kinase Cι as a human oncogene and therapeutic target.

  2014cites this paper
• Beyond Androgen Deprivation

  2014cites this paper
• Protein kinase C and cancer: what we know and what we do not

  2014cites this paper
• The role of activation-induced cytidine deaminase expression in gastric adenocarcinoma.

  2014cites this paper
• Cytokine Effects on Cell Viability and Death of Prostate Carcinoma Cells

  2014cites this paper
• Increased aPKC Expression Correlates with Prostatic Adenocarcinoma Gleason Score and Tumor Stage in the Japanese Population

  2014cites this paper
• Addiction of Prostate Cancer Beyond Androgen Deprivation : Ancillary Integrative Strategies for Targeting the Androgen Receptor

  2014cites this paper
• Role of aPKCl in epidermal morphogenesis and homeostasis

  2013cites this paper
• Loss of APKC expression independently predicts tumor recurrence in superficial bladder cancers.

  2013cites this paper
• Par-complex aPKC and Par3 cross-talk with innate immunity NF-κB pathway in epithelial cells

  2013cites this paper
• Protein Kinase C iota as a Therapeutic Target in Alveolar Rhabdomyosarcoma

  2012cites this paper
• Regulation of Cdk7 activity through a phosphatidylinositol (3)-kinase/PKC-ι-mediated signaling cascade in glioblastoma.

  2012cites this paper
• PKCε mediates NF-κB signaling in prostate cancer 1 ACTIVATION OF NUCLEAR FACTOR – KAPPA B (NF-κB) IN PROSTATE CANCER IS MEDIATED BY PKC EPSILON (PKCε)

  2012cites this paper
• Role of Protein kinase C-iota in Glioblastoma

  2011cites this paper
• THE ROLE OF CYCLIN E IN PKC IOTA-DRIVEN EARLY OVARIAN TUMORIGENESIS

  2011cites this paper
• Hyperglycemia Enhances IGF-I–Stimulated Src Activation via Increasing Nox4-Derived Reactive Oxygen Species in a PKCζ-Dependent Manner in Vascular Smooth Muscle Cells

  2011cites this paper
• Protein kinase Cι expression and oncogenic signaling mechanisms in cancer

  2011cites this paper
• PKC-ι promotes glioblastoma cell survival by phosphorylating and inhibiting BAD through a phosphatidylinositol 3-kinase pathway.

  2011cites this paper
• A Proteomic Investigation of B Lymphocytes in an Autistic Family: A Pilot Study of Exposure to Natural Rubber Latex (NRL) May Lead to Autism

  2011cites this paper
• Atypical PKCs as Targets for Cancer Therapy

  2010cites this paper
• PKC and the Control of Apoptosis

  2010cites this paper
• The Role of PKCι in Cell Polarity, Mitosis and Cancer

  2010cites this paper
• Identification of Potential Pathway Mediation Targets in Toll-like Receptor Signaling

  2009cites this paper
• aPKCλ/ι promotes growth of prostate cancer cells in an autocrine manner through transcriptional activation of interleukin-6

  2009cites this paper
• The effect of CLAs on the expression of PKC isoforms and cell viability in breast cancer cell lines.

  2008cites this paper
• Oncogenic PKC-ι activates Vimentin during Epithelial-Oncogenic PKC-activates Vimentin during Epithelial-mesenchymal Transition in Melanoma; A Study based on PKC-ι mesenchymal Transition in Melanoma; A Study based on PKC-and PKC-ζ specific Inhibitors and PKC-specific Inhibitors

  year unknowninfluential citation